Research

Mixed

Anti-obesity medications (AOMs) are significantly underutilized in clinical practice, with only 1.4% of eligible patients receiving prescriptions despite nearly half of the adult population meeting eligibility criteria.

If you are eligible for anti-obesity medications based on your BMI and health conditions, you are not currently receiving them in most cases. This is not necessarily a reflection of your health status but a systemic gap in care. Discussing these options with your provider and understanding insurance coverage is essential, as prescription rates remain extremely low despite high eligibility.

GoodRefutesHIGH confidence
Of these, 69.4% (31.2% of overall cohort) had BMI ≥ 30 kg/m2. AOM prescription was observed in 15,214 (1.4%) of all eligible patients... Although nearly one-half of all patients in a large health care system were AOM-eligible by guidelines and regulatory labeling, only 1% of those who were eligible were prescribed AOMs.
John W. Ostrominski et al. · Obesity · 2024

Why this rating

Large-scale cross-sectional analysis of over 2.4 million patients in a major integrated health system provides high statistical power, though it is observational.

Source

Contemporary treatment patterns of overweight and obesity: insights from the Mass General Brigham health care system

John W. Ostrominski et al. · Obesity · 2024

DOI 10.1002/oby.24186

cross_sectional · n=2469474Cited 6×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →